Taq DNA Polymerase Mutants for Higher PCR Amplification Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods fail to enhance the efficiency and effectiveness of PCR detection technology by modifying Taq enzyme, which is limited by solubility and stability issues when additional domains are added, and by the complexity and unpredictability of site-directed mutations.
Innovation Solution
A mutated DNA polymerase with specific amino acid sequences, such as E507A, K508L, E734E, F749K, and others, is developed through directed evolution to improve amplification activity, achieving at least 1.2 times higher activity than wild-type Taq enzyme.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If domains are added to Taq enzyme to enhance binding and extension ability, then amplification activity is improved, but molecular weight increases which reduces solubility and stability
Solution Approach 1:
The patent removes the 5'-3' exonuclease domain (first 280 amino acids of N-terminus) from Taq enzyme to retain only the essential polymerase active region. This extraction eliminates harmful degradation activity while preserving amplification function, resolving the contradiction between enhancing activity and maintaining stability.
Solution Approach 2:
The patent performs site-directed mutations at specific amino acid positions (e.g., K508L, F749V, E734Q) to optimize substrate binding affinity and catalytic efficiency. These parameter changes at critical positions enhance amplification activity without increasing molecular weight, thus maintaining solubility and stability.
2Productivity
If the 5'-3' exonuclease domain is deleted to improve polymerization activity, then primer and template degradation is reduced, but 5'-3' exonuclease activity is lost limiting quantitative PCR application
Solution Approach 1:
The patent selectively removes only the 5'-3' exonuclease domain while preserving the polymerase domain, achieving improved polymerization activity by eliminating degradation activity. The truncation creates a specialized enzyme optimized for amplification without the side effect of nucleic acid degradation.
3Reliability
If site-directed mutation is performed to increase substrate affinity, then tolerance to inhibitors is improved, but the complexity of protein structure makes prediction difficult and workload increases
Solution Approach 1:
The patent focuses mutations at specific local positions (e.g., K508, F749, E734) that are critical for substrate binding and catalysis. By concentrating mutagenesis efforts at these key positions rather than throughout the entire protein, the patent improves inhibitor tolerance while significantly reducing the complexity and workload of mutation screening.
Solution Approach 2:
The patent uses bioinformatic analysis and structural modeling to identify promising mutation positions before performing site-directed mutagenesis. This preliminary identification of critical residues (such as those in the active site and substrate binding region) guides the mutagenesis process, reducing the need for extensive screening of random mutants.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutated DNA polymerase significantly enhances PCR amplification efficiency, producing more products in fewer cycles or the same time as wild-type Taq enzyme, thus improving PCR detection capabilities.
Implementation Method 1
a mutated DNA polymerase with specific amino acid sequences, such as E507A, K508L, E734E, F749K, and others, is developed through directed evolution to improve amplification activity
Data Source
AI summary
The present invention provides a heat-resistant DNA polymerase mutant with high amplification activity. Particularly, the present invention uses protein directed evolution technology to construct a random mutation library for the polymerase active domain of Taq enzyme, and gradually adds screening pressure, so that unsuitable mutations will be eliminated naturally, and mutations with dominant traits will gradually accumulate. Finally, a series of amino acid sites and their mutations that are critical to Taq enzyme amplification and polymerization performance will be selected, and a Taq enzyme mutant with high amplification activity will be obtained.